Analysis

A recent webinar focused on seven key predictions for the upcoming year when it comes to GLP-1 drugs and their impact on employee benefits.

The new year brings a host of new health care industry changes and regulatory compliance issues that will challenge employers--and they'll be looking to their broker partners to help them stay ahead of deadlines and keep abreast of new legislation.

Specialty drug costs keep going up for plan sponsors Here are a few considerations employers and their brokers and consultants need to take into account in the coming years.   

Is health coverage affordable? Depends on who you ask.

Heading into the new year, perceived coverage gaps, flexibility, and affordability receive more attention as companies weigh prioritizing value versus shifting costs. 

Employees give high marks overall to their voluntary benefits enrollments, but employers and theier benefits advisors may be missing opportunities to increase satisfaction and participation.